|
 |
Product Information anti-kappa/anti Lambda - light chain
|
|
|
Antigen distribution:
Kappa light chains of human immunoglobulins occur in 50-70% of normal human B lymphocytes while Lambda light chains are expressed in 30-50% of these cells. Abnormal expression of kappa and lambda light chains occur in leukemia.
Application:
Polyclonal anti-kappa and anti-lambda antibodies can be applied in flow cytometry for analysis of blood samples. Rabbit anti-human kappa light chain
is intended for use in flow cytometry and is available in combination with anti-human Lambda, with anti-CD19 or as a triple antibody i.e. anti-kappa
plus anti-lambda plus anti-CD19. Anti-kappa and anti-lambda antibodies are frequently used in combination with anti-CD19 for the detection of light
chains of surface immunoglobulin on normal and neoplastic B cells. These reagents are especially valuable in the study of the monoclonal nature (light
chain restriction) of lymphoid neoplasms.
Specifications:
Anti-human kappa light chain polyclonal antibody is the F(ab')2 fragment of the purified immunoglobulin fraction of rabbit anti-serum.
Anti-human lambda light chain polyclonal antibody is the F(ab')2 fragment of the purified immunoglobulin fraction of goat anti-serum. These
antibodies react with free light chains as well as intact immunoglobulin molecules.
References:
1. Stanworth, D.R., and Turner,W.W., 1987. In Handbook of Experimental Immunology, 3rd edition. Weir,D.M., eds. Blackwell Oxford.
2. Picker, L.J., et al., 1987, Am.J.Path., 128. 181
For research only. Not for use in humans. For in vitro use only.
|
|